Varsetatug masetecan is a first-in-class ADC that pairs a monoclonal antibody against EpCAM with a topoisomerase 1 inhibitor ...
InxMed Co., Ltd ('InxMed'), a clinical-stage biotechnology company dedicated to developing innovative therapies targeting ...
Video webcast now available hereTAMPA, Fla. and LONDON, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: ...
A protein that sticks cells and tissues together has been found to have a surprising second job: helping cells that are ...
Fast Track Designation follows encouraging Phase 1 data that were previously reported for R/R mCRC -- Potential Varseta-M monotherapy ...
Researchers from the University of Turku in Finland and the Gustave Roussy Institute in France have identified a molecular ...
Decoding the cardiac cellular universe: primary cell resources for dissecting heart microenvironment-driven disease ...
Researchers from the University of Turku in Finland and Gustave Roussy Institute in France have discovered a molecular ...
The results suggest a potential way of slowing the spread of cancer, but further research and clinical trials are still ...
A microfluidic device developed by scientist Mehmet Toner and his colleagues is helping researchers isolate rare circulating ...
A new study found that cannabidiol (CBD) significantly inhibited the growth and biofilm formation of Streptococcus oralis, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results